NSEDisclosure under SEBI Takeover Regulations30 Jun 2026 · 30 Jun 2026, 12:49 pm
Disclosure under SEBI Takeover Regulations
Bafna Pharmaceuticals Limited · BAFNAPH
✦ AI SummaryRegulatory
Bafna Pharmaceuticals Limited has submitted a disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year ended on 31st March, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bafna Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Attachments (1)
📄pdf
Download →
team_bbodade_12052026162248_BAFNAPH.pdf
View document text
BAFNA PHARMACEUTICALS LIMITED
REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA
PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com
CIN: L24294TN1995PLCO30698
Date: April 07, 2026
BSE Limited, National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex,
Mumbai - 400001. Bandra East, Mumbai – 400051.
Scrip Code: 532989 Scrip Code: BAFNAPH
Dear Sir/Madam,
Sub: Disclosures under Regulation 31 (4) of SEBI (Substantial Acquisition of
Shares & Takeovers) Regulations, 2011
Please find enclosed herewith the Annual Disclosure under Regulation 31(4) of
SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011, for the
financial year ended on 31st March, 2026, as received from the Promoters of the
Company.
We request you to take the information on record.
Thanking You.
For BAFNA PHARMACEUTICALS LIMITED
Mohanachandran A
Company Secretary & Compliance Officer
Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com